Bhatt DL, Kandzari DE, O'Neill WW, et al. The SYMPLICITY HTN-3 Investigators. A controlled trial of renal denervation for resistant hypertension. N Engl J 2014; 370(15): 1393–1401.
2.
KrumHSchlaichMWhitbournR. Catheter-based renal sympathetic denervation for resistant hypertension: A multicentre safety and proof-of-principle cohort study. Lancet2009; 373: 1275–1281.
3.
EslerMDKrumHSobotkaPA. Symplicity HTN-2 Investigators. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): A randomized controlled trial. Lancet2010; 376: 1903–1909.
4.
KandzariDEBhattDLSobotkaPA. Catheter-based renal denervation for resistant hypertension: Rationale and design of the SYMPLICITY HTN-3 Trial. Clin Cardiol2012; 35: 528–535.
5.
BlankestijnPJRitzE. Renal denervation: Potential impact on hypertension in kidney disease?Nephrol Dial Transplant2011; 26: 2732–2734.
6.
VinkEEBlankestijnPJ. Evidence and consequences of the central role of the kidneys in the pathophysiology of sympathetic hyperactivity. Front Physiol2012; 3: 29–29.
7.
VinkEEDe JagerRLBlankestijnPJ. Sympathetic hyperactivity in chronic kidney disease: Pathophysiology and (new) treatment options. Curr Hypertens Rep2013; 15: 95–101.
8.
VinkEEBotsMLBlankestijnPJ. Renal denervation as therapy for hypertension: Potentials and unanswered questions. Eur J Prev Cardiol2013; 20: 980–991.
9.
BeusEDe JagerRJolesJA. Sympathetic activation in chronic kidney disease: Therapeutic target for renal denervation?J Hypertens2014; PubMed PMID: 24805954–24805954.
VerloopWLVinkEEVoskuilM. Eligibility for percutaneous renal denervation: The importance of a systematic screening. J Hypertens2013; 31: 1662–1668.
12.
Persu A, Jin Y, Baelen M, Vink E, et al. on behalf of the European Network Coordinating research on Renal Denervation (ENCOReD) Consortium. Eligibility for renal denervation: Experience at 11 European Expert Centers. Hypertension. Epub ahead of print 24 March 2014. PubMed PMID: 24664290.
13.
VinkEEVerloopWLBostRB. The blood pressure lowering effect of renal denervation is inversely related to kidney function. J Hypertens 2014. (in press).
14.
VinkEEGoldschmedingRVinkA. Limited destruction of renal nerves after catheter based renal denervation. Results of a human case study. Nephrol Dial Transplant 2014. (in press).
15.
JungOGechterJLWunderC. Resistant hypertension? Assessment of adherence by toxicological urine analysis. J Hypertens2013; 31: 766–774.